Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Notice of Meeting, 47469 [2014-19146]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 156 / Wednesday, August 13, 2014 / Notices
Technology Transfer on or before
September 12, 2014 will be considered.
ADDRESSES: Requests for copies of the
patent application, inquiries, and
comments relating to the contemplated
exclusive license should be directed to:
Sabarni K. Chatterjee, Ph.D., M.B.A.,
Licensing and Patenting Manager,
Cancer Branch, Office of Technology
Transfer, National Institutes of Health,
6011 Executive Boulevard, Suite 325,
Rockville, MD 20852–3804; Telephone:
(301) 435–5587; Facsimile: (301) 435–
4013; Email: chatterjeesa@od.nih.gov.
SUPPLEMENTARY INFORMATION: The
technology identifies a set of noninvasive metabolic biomarkers in urine
samples that are mechanistically
associated with colorectal
carcinogenesis in a mouse model. In
addition, pathways related to the
production of these metabolites are also
found to be dys-regulated in human
colorectal cancer tissues. These indicate
that changes in urinary metabolites may
be helpful in screening and diagnosis of
colorectal cancers. Furthermore, the
mechanistic association of these
pathways with proliferation suggests
that these biomarkers may also be
helpful in evaluating and monitoring
therapeutic response, remission and
relapse in colorectal cancer patients.
This technology is intended for use as
an adjunctive screening test for the
detection of colorectal tumor or
adenoma. A positive result may indicate
the presence of colorectal cancer or
premalignant colorectal neoplasia
(adenoma). This urine based screen
would not replace colonoscopy but
would assist in the recommendation for
additional testing or intervention.
Compared to colonoscopy, the currently
most commonly used colorectal cancer
screening/diagnostic test, the test based
on this new technology is non-invasive,
cost effective and safer. This technology
would be intended for patients who are
typical candidates for colorectal cancer
screening, adults of either sex, 50 years
or older, who are at average risk of
developing colorectal cancer.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR Part 404. The
prospective exclusive license may be
granted unless within thirty (30) days
from the date of this published notice,
the NIH receives written evidence and
argument that establishes that the grant
of the license would not be consistent
with the requirements of 35 U.S.C. 209
and 37 CFR Part 404.
Applications for a license in the field
of use filed in response to this notice
will be treated as objections to the grant
VerDate Mar<15>2010
18:15 Aug 12, 2014
Jkt 232001
of the contemplated exclusive license.
Comments and objections submitted to
this notice will not be made available
for public inspection and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: August 11, 2014.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2014–19144 Filed 8–12–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development (NICHD); Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Child Health and
Human Development Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available. A
portion of this meeting will be closed to
the public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review and
discussion of grant applications.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the contact person listed below in
advance of the meeting.
Name of Committee: National Advisory
Child Health and Human Development
Council.
Date: September 18, 2014.
Open: September 18, 2014, 8:00 a.m. to
12:00 p.m.
Agenda: Report of the Director, NICHD;
Report of the Director, Division of Extramural
Research, NICHD; Report of the Scientific
Director, Division of Intramural Research; a
presentation on the Outstanding Investigator
Award (R35); and New Business of the
Council.
Closed: September 18, 2014, 1:00 p.m. to
Adjournment.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Center Drive, C-Wing,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Cathy Y. Spong, M.D.,
Director, Division of Extramural Research,
Eunice Kenney Shriver National Institute of
Child Health and Human Development, NIH,
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
47469
6100 Executive Blvd., Room 4A05, MSC
7510, Bethesda, MD 20892, (301) 435–6894.
Any interested person may file written
comments with the committee by forwarding
the statement to the contact person listed on
this notice. The statement should include the
name, address, telephone number, and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles,
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
In order to facilitate public attendance at
the open session of Council in the main
meeting room, Conference Room 10, please
contact Ms. Lisa Kaeser, Program and Public
Liaison Office, NICHD, at 301–496–0536 to
make your reservation, additional seating
will be available in the meeting overflow
rooms, Conference Rooms 7 and 8.
Individuals will also be able to view the
meeting via NIH Videocast. Please go to the
following link for Videocast access
instructions at: https://www.nichd.nih.gov/
about/advisory/nachhd/Pages/virtualmeeting.aspx.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: August 7, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–19146 Filed 8–12–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Clinical Trials
and Translational Research Advisory
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
E:\FR\FM\13AUN1.SGM
13AUN1
]]>Agencies
[Federal Register Volume 79, Number 156 (Wednesday, August 13, 2014)]
[Notices]
[Page 47469]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-19146]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development (NICHD); Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Child Health and Human Development Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. A portion of this meeting will
be closed to the public in accordance with the provisions set forth in
sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended for the
review and discussion of grant applications. Individuals who plan to
attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
contact person listed below in advance of the meeting.
Name of Committee: National Advisory Child Health and Human
Development Council.
Date: September 18, 2014.
Open: September 18, 2014, 8:00 a.m. to 12:00 p.m.
Agenda: Report of the Director, NICHD; Report of the Director,
Division of Extramural Research, NICHD; Report of the Scientific
Director, Division of Intramural Research; a presentation on the
Outstanding Investigator Award (R35); and New Business of the
Council.
Closed: September 18, 2014, 1:00 p.m. to Adjournment.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, Center Drive,
C-Wing, Conference Room 6, Bethesda, MD 20892.
Contact Person: Cathy Y. Spong, M.D., Director, Division of
Extramural Research, Eunice Kenney Shriver National Institute of
Child Health and Human Development, NIH, 6100 Executive Blvd., Room
4A05, MSC 7510, Bethesda, MD 20892, (301) 435-6894.
Any interested person may file written comments with the
committee by forwarding the statement to the contact person listed
on this notice. The statement should include the name, address,
telephone number, and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles, will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
In order to facilitate public attendance at the open session of
Council in the main meeting room, Conference Room 10, please contact
Ms. Lisa Kaeser, Program and Public Liaison Office, NICHD, at 301-
496-0536 to make your reservation, additional seating will be
available in the meeting overflow rooms, Conference Rooms 7 and 8.
Individuals will also be able to view the meeting via NIH Videocast.
Please go to the following link for Videocast access instructions
at: https://www.nichd.nih.gov/about/advisory/nachhd/Pages/virtual-meeting.aspx.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: August 7, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-19146 Filed 8-12-14; 8:45 am]
BILLING CODE 4140-01-P
